The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries

Table 2

Gastrointestinal symptoms and bleeding in patients.

	Aspirin ()	Aspirin+teprenone ()	value
3-Month gastrointestinal symptoms, (%)	2 (1.47)	0 (0)	0.494
6-Month gastrointestinal symptoms, (%)	9 (6.62)	2 (1.53)	0.036
12-Month gastrointestinal symptoms, (%)	28 (20.59)	4 (3.05)	0.000
Total gastrointestinal symptoms, (%)	39 (28.68)	6 (4.58)	0.000
3-Month gastrointestinal bleeding, (%)	1 (0.74)	1 (0.76)	0.488
6-Month gastrointestinal bleeding, (%)	2 (1.47)	0 (0)	0.494
12-Month gastrointestinal bleeding, (%)	5 (3.68)	1 (0.76)	0.233
Total gastrointestinal bleeding, (%)	8 (5.88)	2 (1.52)	0.004